Author:
Lin Guihan,Chen Weiyue,Fan Yingying,Zhou Yi,Li Xia,Hu Xin,Cheng Xue,Chen Mingzhen,Kong Chunli,Chen Minjiang,Xu Min,Peng Zhiyi,Ji Jiansong
Funder
National Natural Science Foundation of China
Reference42 articles.
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA: Cancer J Clin,2021
2. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial;Krag;Lancet Oncol,2010
3. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients;Langer;Ann Surg,2007
4. Validation of six nomograms for predicting non-sentinel lymph node metastases in a dutch breast cancer population;Dingemans;Ann Surg Oncol,2016
5. Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node;Mittendorf;Ann Surg,2012